RT Journal Article
SR Electronic
T1 683 Phase I first-in-human study on the feasibility, safety, and antitumor activity of CD4-redirected chimeric antigen receptor (CAR) T-cell therapy in patients with CD4+ T-cell malignancies (TCM)
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A775
OP A776
DO 10.1136/jitc-2023-SITC2023.0683
VO 11
IS Suppl 1
A1 Assi, Rita
A1 Hagag, Nabil
A1 Farag, Sherif
A1 Emmons, Robert
A1 Carter, Allie
A1 Czader, Magdalena
A1 Abonnour, Rafat
A1 Apetoh, Lionel
A1 Ma, Yupo
A1 Salman, Huda
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A775.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.